OKUR OnKure Yalpi foyda normasi

OnKure Therapeutics Inc (OKUR) korporativ emblemasi va logotipi

OnKure Therapeutics Inc kompaniyasining yalpi foyda marjasi ko'rsatkich 0.00 atrofida qolayotgan tendentsiyani namoyish etmoqda, shu bilan birga AQSh laboratoriyalari klinik sinovlar orqali innovatsion molekulalarni rivojlantirmoqda. Kelajakdagi yuqori marjalar aniq onkologik terapiya usullari uchun olingan patentlar bilan ta'minlangan. Shu bilan birga, dori vositalarini ishlab chiqish barqaror AQSh huquqiy bazasi doirasida davom etmoqda, bu esa tashqi sanksiyalar bosimi xatarlarini butunlay yo'qqa chiqaradi.

Yalpi foyda bo'yicha rentabellik: OnKure (OKUR) 08.10.2024 - 20.11.2026 uchun

OnKure (OKUR) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- pul pozitsiyasi va pul oqimlari tafsilotlari:
Fundamental baholash:OKUR onkuretherapeutics.com
OnKure Therapeutics, Inc. yetakchi tovari

Yalpi foyda chegarasi umumiy daromad va bevosita ishlab chiqarish xarajatlari orasidagi farqning sotuvlar hajmiga nisbati sifatida hisoblanadi va asosiy xarajatlarni boshqarish samaradorligini belgilaydi. OnKure Therapeutics Inc (OKUR) uchun ushbu ko'rsatkich aniqlik onkologiyasi segmentida maqsadli ingibitorlarni ishlab chiqishning daromadliligini aks ettiradi, yalpi foyda chegarasidagi farq esa kompaniyaning dori vositalarini ishlab chiqish xarajatlarini bozor talabiga nisbatan optimallashtirish qobiliyatidan dalolat beradi.

Asosiy raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi marja Kairos Pharma (KAPA)|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik